Antineutrophil cytoplasmic antibodies in Estonian patients with inflammatory bowel disease. Prevalence and diagnostic role
- PMID: 9951879
Antineutrophil cytoplasmic antibodies in Estonian patients with inflammatory bowel disease. Prevalence and diagnostic role
Abstract
Background/aims: In Estonia, the incidence of ulcerative colitis and especially Crohn's disease appears to be rare. Antineutrophil cytoplasmic antibodies (ANCA) are frequently found in ulcerative colitis but less frequently in Crohn's disease, their pathophysiological significance is still unclear.
Methodology: Fifty-nine serum samples from patients with ulcerative colitis, 17 with Crohn's disease, 25 with irritable bowel syndrome, and 86 healthy persons were studied. Sera were analyzed for the presence of ANCA by indirect immunofluorescence, and enzyme-linked immunosorbent assay for specific ANCA using different antigens was performed.
Results: ANCA were detected in 29 of 59 (49%) patients with ulcerative colitis, 4 of 17 (24%) patients with Crohn's disease, and in 4 of 111 (4%) controls. The immunofluorescence staining was mostly perinuclear (pANCA). There was no correlation between ANCA and the duration or extent of the inflammatory bowel disease. In specific enzyme-linked immunosorbent assays, only 14 sera elicited binding above the normal range.
Conclusions: Although the prevalence of ulcerative colitis and Crohn's disease in Estonia is much lower than in European countries, there seem to be no differences in the presence of ANCA.
Similar articles
-
[antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease].Med Clin (Barc). 1998 Jan 17;110(1):11-5. Med Clin (Barc). 1998. PMID: 9527980 Spanish.
-
Antineutrophil cytoplasmic antibodies in Japanese patients with inflammatory bowel disease: prevalence and recognition of putative antigens.Am J Gastroenterol. 1999 May;94(5):1304-12. doi: 10.1111/j.1572-0241.1999.01081.x. Am J Gastroenterol. 1999. PMID: 10235211
-
Antineutrophil cytoplasmic antibodies in relatives of patients with inflammatory bowel disease.Am J Gastroenterol. 1996 Aug;91(8):1512-5. Am J Gastroenterol. 1996. PMID: 8759652
-
Serologic markers in inflammatory bowel disease: state of the art.Rev Gastroenterol Disord. 2004 Fall;4(4):167-74. Rev Gastroenterol Disord. 2004. PMID: 15580151 Review.
-
Antineutrophil cytoplasmic antibodies in inflammatory bowel disease: clinical role and review of the literature.Dis Colon Rectum. 2000 Jul;43(7):999-1007. doi: 10.1007/BF02237367. Dis Colon Rectum. 2000. PMID: 10910250 Review.
Cited by
-
Biological therapy in inflammatory bowel diseases: access in Central and Eastern Europe.World J Gastroenterol. 2015 Feb 14;21(6):1728-37. doi: 10.3748/wjg.v21.i6.1728. World J Gastroenterol. 2015. PMID: 25684937 Free PMC article. Review.
-
Perinuclear anti-neutrophil cytoplasmic antibodies (p-anca) in chronic ulcerative colitis: experience in a Mexican institution.World J Gastroenterol. 2006 Jun 7;12(21):3406-9. doi: 10.3748/wjg.v12.i21.3406. World J Gastroenterol. 2006. PMID: 16733859 Free PMC article.
-
Management of inflammatory bowel diseases in Eastern Europe.Postgrad Med J. 2006 Apr;82(966):270-3. doi: 10.1136/pgmj.2005.043901. Postgrad Med J. 2006. PMID: 16597815 Free PMC article. Review.
-
Optimising the diagnostic value of anti-Saccharomyces cerevisiae-antibodies (ASCA) in Crohn's disease.Int J Colorectal Dis. 2004 Jul;19(4):319-24. doi: 10.1007/s00384-003-0557-1. Epub 2004 Jan 27. Int J Colorectal Dis. 2004. PMID: 14745572
-
Inflammatory bowel disease in Estonia: a prospective epidemiologic study 1993-1998.World J Gastroenterol. 2001 Jun;7(3):387-8. doi: 10.3748/wjg.v7.i3.387. World J Gastroenterol. 2001. PMID: 11819795 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical